Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.92
-0.55 (-7.36%)
Aug 25, 2025, 4:00 PM - Market closed
Lyra Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Lyra Therapeutics stock has a target of 16, which predicts a 131.21% increase from the current stock price of 6.92.
Price Target: $16 (+131.21%)
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Lyra Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 3 | 3 | 3 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $16 | Hold | Reiterates | $16 | +131.21% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $2 → $16 | Hold | Maintains | $2 → $16 | +131.21% | Jun 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +1,345.09% | Mar 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $100 | Hold | Reiterates | $100 | +1,345.09% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
724.97K
from 1.53M
Decreased by -52.74%
Revenue Next Year
1.73M
from 724.97K
Increased by 139.18%
EPS This Year
-14.54
from -71.75
EPS Next Year
-25.01
from -14.54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 4.2M | 15.6M | ||
| Avg | 724,965 | 1.7M | 15.2M | ||
| Low | 196,000 | 392,000 | 14.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.7% | 479.3% | 802.5% | ||
| Avg | -52.7% | 139.2% | 776.7% | ||
| Low | -87.2% | -45.9% | 742.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.54 | -15.82 | -13.91 |
| Avg | -14.54 | -25.01 | -13.52 |
| Low | -31.36 | -42.14 | -12.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.